A Unified Whole Lung PBK Model for Inhalational Uptake of Gases and Aerosols in Men
Open Access
- 4 October 2025
- journal article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 14 (12) , 2173-2185
Abstract
Assessing the risk or benefit of an inhaled substance is challenging due to the variety of forms it can take (gas, vapor, particle, or droplet) and the complex biological processes involved in its uptake and retention. Physiologically based kinetic (PBK) models offer an alternative to in vivo experiments. However, PBK models for inhalational uptake are to date either designed for gases/vapors or airborne particulates, often with only low regional compartmentalization. The here‐presented, newly developed model combines both applications. Its mechanisms are an amalgamation of PBK and non‐PBK models integrated into a multicompartmental description of the human lung to include the relevant uptake and clearance processes in the different lung regions, of which macrophage‐mediated dissolution is novel to PBK modeling. The model was designed to use a minimal number of substance‐specific input parameters, which can be derived from in vitro assays or in silico methods. Model predictions for hypothetical substances with varying physicochemical properties were performed, along with rudimentary sensitivity analyses to identify the most important parameters for gases/vapors and particles. This novel PBK model combines all these aspects and provides in silico predictions of systemic and local lung concentrations, reducing uncertainty in risk assessments and supporting drug development. It serves as a valuable tool to translate nominal ambient air doses into effective localized doses within the lung.Keywords
This publication has 43 references indexed in Scilit:
- Modelling the biodistribution of inhaled gold nanoparticles in rats with interspecies extrapolation to humansToxicology and Applied Pharmacology, 2022
- Physicochemical properties affecting the fate of nanoparticles in pulmonary drug deliveryDrug Discovery Today, 2020
- A Partial Differential Equation Approach to Inhalation Physiologically Based Pharmacokinetic ModelingCPT: Pharmacometrics & Systems Pharmacology, 2018
- Surface area is the biologically most effective dose metric for acute nanoparticle toxicity in the lungJournal of Aerosol Science, 2016
- Development of a Multicompartment Permeability‐Limited Lung PBPK Model and Its Application in Predicting Pulmonary Pharmacokinetics of Antituberculosis DrugsCPT: Pharmacometrics & Systems Pharmacology, 2015
- Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcomeEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Phagocytosis Dynamics Depends on Target ShapeBiophysical Journal, 2013
- Biologically-based modeling insights in inhaled vapor absorption and dosimetryPharmacology & Therapeutics, 2012
- Exploring Primary Liver Macrophages for Studying Quantum Dot Interactions with Biological SystemsAdvanced Materials, 2010
- A Multiple-Path Model of Particle Deposition in the Rat LungFundamental and Applied Toxicology, 1995